These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Who or what is the source of antibiotic resistance? Bergogne-Bérézin E J Med Microbiol; 1997 Jun; 46(6):461-4. PubMed ID: 9379476 [No Abstract] [Full Text] [Related]
27. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors. Maddux MS Pharmacotherapy; 1991; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831 [TBL] [Abstract][Full Text] [Related]
28. [Antibiotic resistance: current problems and prospects]. Mazza P Boll Chim Farm; 1994 Nov; 133(10):643-50. PubMed ID: 7865196 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of bacterial antibiotic resistance. Jenkins SG New Horiz; 1996 Aug; 4(3):321-32. PubMed ID: 8856749 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance. Resistance mediated by inhibitor-resistant and extended-spectrum TEM and SHV beta-lactamases. Amyes SG J Med Microbiol; 1997 Jun; 46(6):454-7. PubMed ID: 9379474 [No Abstract] [Full Text] [Related]
31. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs. Schito GC; Pesce A; Debbia EA Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761 [TBL] [Abstract][Full Text] [Related]
32. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. Aldridge KE; Sanders CV; Marier RL J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724 [TBL] [Abstract][Full Text] [Related]
33. A review of the influence of treatment strategies on antibiotic resistant bacteria and antibiotic resistance genes. Sharma VK; Johnson N; Cizmas L; McDonald TJ; Kim H Chemosphere; 2016 May; 150():702-714. PubMed ID: 26775188 [TBL] [Abstract][Full Text] [Related]
34. Problems and dilemmas of antimicrobial resistance. Murray BE Pharmacotherapy; 1992; 12(6 Pt 2):86S-93S. PubMed ID: 1480504 [TBL] [Abstract][Full Text] [Related]
35. Antimicrobials: modes of action and mechanisms of resistance. McDermott PF; Walker RD; White DG Int J Toxicol; 2003; 22(2):135-43. PubMed ID: 12745995 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic resistance: an editorial review with recommendations. Rosen T J Drugs Dermatol; 2011 Jul; 10(7):724-33. PubMed ID: 21720654 [TBL] [Abstract][Full Text] [Related]
38. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
39. Implications of bacterial resistance for the use of beta-lactam agents in clinical practice. Richards GA; Klugman KP S Afr Med J; 1993 Mar; 83(3):163-4. PubMed ID: 8511679 [No Abstract] [Full Text] [Related]
40. [Evolutionary strategy of antibiotic resistance]. Courvalin P Bull Mem Acad R Med Belg; 2002; 157(5-6):301-8; discussion 308-9. PubMed ID: 12557574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]